Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   An overview of enzymatic reagents for the removal of affinity tags
  2. Waugh, D. S.
  3. Protein Expression and Purification. 2011, Dec; 80(2): 283-293.
  1. 2.   Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication
  2. Li, B.; Peet, N. P.; Butler, M. M.; Burnett, J. C.; Moir, D. T.; Bowlin, T. L.
  3. Molecules. 2011, Jan; 16(1): 202-220.
  1. 3.   Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system
  2. Tsai, Y. C.; Maditz, R.; Kuo, C. L.; Fishman, P. S.; Shoemaker, C. B.; Oyler, G. A.; Weissman, A. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Sep; 107(38): 16554-16559.
  1. 4.   Iterative Structure-Based Peptide-Like Inhibitor Design against the Botulinum Neurotoxin Serotype A
  2. Zuniga, J. E.; Hammill, J. T.; Drory, O.; Nuss, J. E.; Burnett, J. C.; Gussio, R.; Wipf, P.; Bavari, S.; Brunger, A. T.
  3. Plos One. 2010, Jun; 5(6): 15.
  1. 5.   Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
  2. Chen, W. Z.; Zhu, Z. Y.; Liao, H. X.; Quinnan, G. V.; Broder, C. C.; Haynes, B. F.; Dimitrov, D. S.
  3. Viruses-Basel. 2010, Feb; 2(2): 547-565.
  1. 6.   SYNTHESIS AND BIOLOGICAL EVALUATION OF INHIBITORS OF BOTULINUM NEUROTOXIN METALLOPROTEASE
  2. Wang, C. B.; Widom, J.; Petronijevic, F.; Burnett, J. C.; Nuss, J. E.; Bavari, S.; Gussio, R.; Wipf, P.
  3. Heterocycles. 2009 79: 487-520.
  1. 7.   Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
  2. Barkan, D.; Kleinman, H.; Simmons, J. L.; Asmussen, H.; Kamaraju, A. K.; Hoenorhoff, M. J.; Liu, Z. Y.; Costes, S. V.; Cho, E. H.; Lockett, S.; Khanna, C.; Chambers, A. F.; Green, J. E.
  3. Cancer Research. 2008 68(15): 6241-6250.
  1. 8.   Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E
  2. Hines, H. B.; Kim, A. D.; Stafford, R. G.; Badie, S. S.; Brueggeman, E. E.; Newman, D. J.; Schmidt, J. J.
  3. Applied and Environmental Microbiology. 2008 74(3): 653-659.
  1. 9.   A Potent Peptidomimetic Inhibitor of Botulinum Neurotoxin Serotype A Has a Very Different Conformation than SNAP-25 Substrate
  2. Zuniga, J. E.; Schmidt, J. J.; Fenn, T.; Burnett, J. C.; Arac, D.; Gussio, R.; Stafford, R. G.; Badie, S. S.; Bavari, S.; Brunger, A. T.
  3. Structure. 2008 16(10): 1588-1597.
  1. 10.   Understanding antibody-antigen associations by molecular dynamics simulations: Detection of important intra- and inter-molecular salt bridges
  2. Sinha, N.; Li, Y. L.; Lipschultz, C. A.; Smith-Gill, S. J.
  3. Cell Biochemistry and Biophysics. 2007 47(3): 361-375.
  1. 11.   An E box comprises a positional sensor for regional differences in skeletal muscle gene expression and methylation
  2. Ceccarelli, E.; McGrew, M. J.; Nguyen, T.; Grieshammer, U.; Horgan, D.; Hughes, S. H.; Rosenthal, N.
  3. Developmental Biology. 1999 213(1): 217-229.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel